ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 259 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $22,221,000 | +74.6% | 239,093 | +11.9% | 0.01% | +66.7% |
| Q3 2021 | $12,725,000 | -13.2% | 213,682 | -0.6% | 0.01% | -14.3% |
| Q2 2021 | $14,661,000 | +4.2% | 214,971 | +6.0% | 0.01% | -12.5% |
| Q1 2021 | $14,069,000 | -11.5% | 202,745 | -2.0% | 0.01% | -20.0% |
| Q4 2020 | $15,896,000 | +8.0% | 206,907 | +5.2% | 0.01% | 0.0% |
| Q3 2020 | $14,715,000 | +15.0% | 196,736 | -3.2% | 0.01% | 0.0% |
| Q2 2020 | $12,798,000 | +12.0% | 203,307 | -25.3% | 0.01% | 0.0% |
| Q1 2020 | $11,426,000 | +17.4% | 272,052 | +26.9% | 0.01% | +66.7% |
| Q4 2019 | $9,735,000 | +16.0% | 214,377 | +16.9% | 0.01% | 0.0% |
| Q3 2019 | $8,392,000 | -32.7% | 183,399 | -13.8% | 0.01% | -14.3% |
| Q2 2019 | $12,471,000 | +9.3% | 212,741 | -16.5% | 0.01% | 0.0% |
| Q1 2019 | $11,414,000 | +272.2% | 254,657 | +223.2% | 0.01% | +250.0% |
| Q4 2018 | $3,067,000 | -86.5% | 78,785 | -84.0% | 0.00% | -71.4% |
| Q3 2018 | $22,659,000 | -8.1% | 492,420 | -12.9% | 0.01% | 0.0% |
| Q2 2018 | $24,648,000 | +83.9% | 565,381 | +66.6% | 0.01% | +16.7% |
| Q1 2018 | $13,405,000 | +113.3% | 339,455 | +83.4% | 0.01% | +50.0% |
| Q4 2017 | $6,284,000 | +183.1% | 185,080 | +112.4% | 0.00% | +100.0% |
| Q3 2017 | $2,220,000 | +14.3% | 87,146 | -24.4% | 0.00% | +100.0% |
| Q2 2017 | $1,942,000 | – | 115,213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| IFP Advisors, Inc | 2 | $1,000 | 0.00% |